Received Oct 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia; had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHIECTASIS (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) and ORGANISING PNEUMONIA (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) in a 78-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 20-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced BRONCHIECTASIS (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) (seriousness criterion medically significant) and ORGANISING PNEUMONIA (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) (seriousness criterion medically significant). At the time of the report, BRONCHIECTASIS (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) and ORGANISING PNEUMONIA (had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia) outcome was unknown. No concomitant medications were reported. It was reported that, she had 2 lung issues which were bronchiectasis and cryptogenic organizing pneumonia which were not specified if those occurred before or after the vaccination. She had read online that she should get a booster but the pharmacist or physician or whoever gave her the shot did not mention it. She confirmed that both her pulmonologist and primary health care provider urged her to get Spikevax, so she had gotten it. She just did not know if she needs a second booster or not. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided.; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.